Revascular Bio Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
4
Revascular Bio General Information
Description
Developer of an angiogenesis cell therapy designed to address intractable diseases. The company offers to deliver endothelial stem cells as pharmaceuticals to treat chronic wounds, such as intractable skin ulcers, severe lower limb ischemia, and cerebrovascular dementia, enabling medical staff to enhance the lives of patients.
Contact Information
Website
www.revascularbio.comCorporate Office
- 3-1 Yamadaoka, Suita
- Osaka, 565-0871
- Japan
Corporate Office
- 3-1 Yamadaoka, Suita
- Osaka, 565-0871
- Japan
Revascular Bio Timeline
Revascular Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Accelerator/Incubator | 05-Mar-2024 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 2. Seed Round | 10-Nov-2023 | $1.47M | $1.67M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 01-Nov-2023 | $200K | $200K | Completed | Generating Revenue |
Revascular Bio Patents
Revascular Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260347793-A1 | Method for producing high-purity vascular endothelial cell population from biological tissue or organ | Pending | 15-May-2023 | ||
| WO-2024237278-A1 | Method for producing high-purity vascular endothelial cell population from biological tissue or organ | Inactive | 15-May-2023 |
Revascular Bio Signals
Revascular Bio Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Kansai Startup Incubation | Accelerator/Incubator | |||
| Intellectual Property Acceleration Program for Startups | Accelerator/Incubator | |||
| Osaka University Venture Capital | Corporate Venture Capital | Minority | ||
| Berkeley SkyDeck | Accelerator/Incubator | Minority |
Revascular Bio FAQs
-
When was Revascular Bio founded?
Revascular Bio was founded in 2022.
-
Where is Revascular Bio headquartered?
Revascular Bio is headquartered in Osaka, Japan.
-
What is the size of Revascular Bio?
Revascular Bio has 9 total employees.
-
What industry is Revascular Bio in?
Revascular Bio’s primary industry is Drug Delivery.
-
Is Revascular Bio a private or public company?
Revascular Bio is a Private company.
-
What is Revascular Bio’s current revenue?
The current revenue for Revascular Bio is .
-
How much funding has Revascular Bio raised over time?
Revascular Bio has raised $1.67M.
-
Who are Revascular Bio’s investors?
Kansai Startup Incubation, Intellectual Property Acceleration Program for Startups, Osaka University Venture Capital, and Berkeley SkyDeck have invested in Revascular Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process